AbbVie (LTS:0QCV) Beginning Cash Position : $7,257 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is AbbVie Beginning Cash Position?

AbbVie's Beginning Cash Position for the quarter that ended in Dec. 2024 was $7,257 Mil.

AbbVie's quarterly Beginning Cash Position declined from Jun. 2024 ($18,067 Mil) to Sep. 2024 ($13,130 Mil) and declined from Sep. 2024 ($13,130 Mil) to Dec. 2024 ($7,257 Mil).

AbbVie's annual Beginning Cash Position declined from Dec. 2022 ($9,746 Mil) to Dec. 2023 ($9,201 Mil) but then increased from Dec. 2023 ($9,201 Mil) to Dec. 2024 ($12,814 Mil).

AbbVie Beginning Cash Position Historical Data

The historical data trend for AbbVie's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Beginning Cash Position Chart

AbbVie Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

39,924.00

8,449.00

9,746.00

9,201.00

12,814.00

AbbVie Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															12,814.00	18,067.00	13,130.00	7,257.00	-

AbbVie Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

AbbVie Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of AbbVie's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (LTS:0QCV) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4AB:Germany ABBVCL:Chile ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria ABBV:Argentina

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

https://www.abbvie.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines